Erratum: Characteristics of copayment offsets for prescription drugs in the United States (JAMA Intern Med (2021) DOI:10.1001/jamainternmed.2021.0733)

Aditi P Sen, So Yeon Kang, E. Rashidi, D. Ganguli, G. Anderson, G. C. Alexander

Research output: Contribution to journalComment/debatepeer-review

Abstract

Errors in Results: In the Original Investigation titled “Characteristics of Copayment Offsets for Prescription Drugs in the United States,”1 published online March 29, 2021, there were data errors in the second sentence of the last paragraph of the Results section. The 2 denominators mentioned in that sentencewere both off by 1 number. The sentence should read as follows: “A total of 80.0% of manufacturer-sponsored offsets were concentrated among 6.2% of unique products (164 of2661 products),and79.9%ofpharmacy-PBMoffsetswere concentratedamong 4.9%of unique products (156 of 3175 products).” The article has been corrected online.

Original languageEnglish (US)
Pages (from-to)883
Number of pages1
JournalJAMA internal medicine
Volume181
Issue number6
DOIs
StatePublished - Jun 2021

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Erratum: Characteristics of copayment offsets for prescription drugs in the United States (JAMA Intern Med (2021) DOI:10.1001/jamainternmed.2021.0733)'. Together they form a unique fingerprint.

Cite this